SHPH Shuttle Pharmaceuticals Hol...

Nasdaq shuttlepharma.com


$ 1.58 $ -0.23 (-12.57 %)    

Friday, 21-Nov-2025 15:54:38 EST
QQQ $ 590.50 $ 4.40 (0.75 %)
DIA $ 462.68 $ 5.05 (1.1 %)
SPY $ 659.10 $ 6.50 (1 %)
TLT $ 89.49 $ 0.27 (0.3 %)
GLD $ 373.70 $ -0.58 (-0.15 %)
$ 1.6
$ 2.09
$ 1.53 x 56
$ 1.59 x 200
$ 1.52 - $ 2.09
$ 1.51 - $ 25.25
3,990,289
na
2.93M
$ 5.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-26-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 09-04-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-25-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-shuttle-pharmaceuticals-shph-stock-surged-overnight

Shuttle Pharmaceuticals shares jumped 27.9% in after-hours trading Thursday after the company filed an S-1 registration stateme...

 shuttle-pharmaceuticals-q3-eps-105-up-from-3975-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.05) per share. This is a 97.36 percent increase over los...

 shuttle-pharma-executes-non-binding-loi-to-acquire-moleculeai-and-its-platform-for-10m-in-combination-of-cash-and-common-shares

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-announces-non-binding-loi-to-purchase-moleculeai-for-10m

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-q2-eps-329-up-from-2412-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over los...

 shuttle-pharmaceuticals-has-been-granted-us-patent-number-12357650-titled-methods-and-compositions-for-cancer-therapies-that-include-delivery-of-halogenated-thymidines-and-thymidine-phosphorlylase-inhibitors-in-combination-with-radiation

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12357650).pn

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION